Certain Ordinary Shares of J Frontier Co.,Ltd. are subject to a Lock-Up Agreement Ending on 26-NOV-2021.
November 25, 2021
Share
Certain Ordinary Shares of J Frontier Co.,Ltd. are subject to a Lock-Up Agreement Ending on 26-NOV-2021. These Ordinary Shares will be under lockup for 91 days starting from 27-AUG-2021 to 26-NOV-2021.
Details:
Atsuhiro Nakamura, the seller and lender, Atsushi Co,Ltd., a shareholder of the Company, Koji Koyama and Hisao Hosei, the holders of the stock acquisition rights of the Company, have agreed not to sell the Company's shares (However, this excludes the underwriting of the underwriter's purchase transaction, the lending of the Company's common stock for sale by over-allotment, and the acquisition of the Company's common stock subject to the green shoe option by the lead managing underwriter.) without prior written consent of the lead managing underwriter during the period from the date of conclusion of the principal underwriting contract to the 90th day (including the day) after the listing (trading start) date (including the day).
In addition, the Company with respect to the main secretary company, listed from the original underwriting agreement entered into after the date (buying and selling start) date (including the day) 180 days ( 2022 year 2 May 22 during the period up to 2008), of the Lead Manager in advance of Issuance of the Company's shares, issuance of securities converted or exchanged for the Company's shares, or issuance of securities entitled to acquire or receive the Company's shares without written consent (however, the Offering and Share Split, etc.) they have agreed not to do such things.
In any of the above cases, the lead managing underwriter has the authority to cancel part or all of the contents of the agreement at its discretion.
In addition to the above, the Company will continue to own the shares, etc. offered by third-party allotment before listing with the person who received the allotment, based on the provisions of the Securities Listing Regulations Enforcement Regulations established by the exchange. they are making promises such as. For details, please refer to "Part 4 Initial Public Offering Information 2 Overview of Third-Party Allotment, etc."
J Frontier Co Ltd is a Japan-based company mainly engaged in the electronic commerce sale business for healthcare-related products and pharmaceuticals, the provision of online medication guidance, drug delivery platform SOKUYAKU, as well as the Internet advertising agency business for healthcare-related services. The Company operates through three business segments. The Healthcare Sales segment is engaged in the planning and development of health foods and cosmetics represented by the 328 selection series of fermented hydrogen and mail-order sales. The Medical Care Sales segment is engaged in the operation of dispensing pharmacies, mail-order business of ethical drugs, as well as planning, development and mail-order sales of drugs such as Why Pure series and Chinese herbs. The Health Care Marketing segment is mainly engaged in advertising agency business related to health care products, sales promotion support for health care products, as well as wholesale of in-house products.